Product
EuRSV
1 clinical trial
2 indications
Indication
Respiratory Syncytial Virus InfectionsIndication
Respiratory Syncytial VirusClinical trial
Phase I, Randomized, Observer-blind, Placebo-control, Parallel-group, first-in Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 YearsStatus: Recruiting, Estimated PCD: 2025-03-31